Beauty Farm Medical and Health Industry Inc. (Stock Code: 02373) published a Next Day Disclosure Return on 27 October 2025, disclosing a repurchase of 40,000 ordinary shares on the same day. The highest and lowest repurchase prices recorded were HKD 31.26 and HKD 30.92 per share, respectively, with a total consideration of HKD 1,244,090.

Following this transaction, the number of shares excluding treasury shares decreased from 235,330,068 to 235,290,068, while treasury shares rose from 465,500 to 505,500. The total number of issued shares remains at 235,795,568. The volume-weighted average repurchase price was reported at HKD 31.1023 per share. No additional cancellations were noted as the repurchased shares are currently held as treasury shares.

According to the disclosure, the repurchase mandate, authorized on 27 June 2025, covers up to 23,579,556 shares. The cumulative number of shares repurchased under this mandate has reached 505,500, representing approximately 0.2144% of the company’s issued shares on the authorization date. The 30-day moratorium on new share issuances or transfers of treasury shares remains in effect until 26 November 2025.